Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-18-015301
Filing Date
2018-03-16
Accepted
2018-03-16 16:29:48
Documents
123
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tv487010_10k.htm 10-K 2819845
2 EXHIBIT 10.39 tv487010_ex10-39.htm EX-10.39 166644
3 EXHIBIT 21.1 tv487010_ex21-1.htm EX-21.1 6696
4 EXHIBIT 23.1 tv487010_ex23-1.htm EX-23.1 2450
5 EXHIBIT 23.2 tv487010_ex23-2.htm EX-23.2 3845
6 EXHIBIT 31.1 tv487010_ex31-1.htm EX-31.1 10363
7 EXHIBIT 31.2 tv487010_ex31-2.htm EX-31.2 10328
8 EXHIBIT 32.1 tv487010_ex32-1.htm EX-32.1 4530
9 EXHIBIT 32.2 tv487010_ex32-2.htm EX-32.2 4497
10 GRAPHIC tv487010_img1.jpg GRAPHIC 42898
  Complete submission text file 0001144204-18-015301.txt   21847474

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT fbio-20171231.xml EX-101.INS 5677405
12 XBRL TAXONOMY EXTENSION SCHEMA fbio-20171231.xsd EX-101.SCH 165232
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fbio-20171231_cal.xml EX-101.CAL 108075
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbio-20171231_def.xml EX-101.DEF 1001205
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbio-20171231_lab.xml EX-101.LAB 1059978
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbio-20171231_pre.xml EX-101.PRE 1093944
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35366 | Film No.: 18695964
SIC: 2834 Pharmaceutical Preparations